Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 120/Piece
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
  • Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
  • Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
  • Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
  • Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
  • Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
Find Similar Products

Basic Info.

Model NO.
Finasteride
Suitable for
Adult
State
Solid
Purity
>99%
Name
Finasteride
CAS
98319-26-7
Mf
C23h36n2o2
MOQ
1kg
Transport Package
Drum
Specification
99%
Trademark
HS
Origin
China
HS Code
2904201000
Production Capacity
100000

Product Description

Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride FinasterideHair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
Product name Finasteride
Cas 98319-26-7
Brand Iknow
Appearance White Powder
Specification 99%
Type Raw Materials
Package 1Kg/25Kg/Drum or As per your request 
Storage  Store in cool and dry places ,keep away from strong light 
Shelf life  2 years when properly stored
What is Finasteride?

Finasteride is an antiandrogen which acts by inhibiting type II 5-alpha reductase.It is used as a treatment in benign prostatic hyperplasia (BPH) in low doses, and prostate cancer in higher doses. It is also indicated for use in combination with doxazosin therapy to reduce the risk for symptomatic progression of BPH. Additionally, it is registered in many countries for androgenetic alopecia (male-pattern baldness).

Finasteride was approved initially in 1992, a treatment for prostate enlargement, but the sponsor had studied 1 mg of finasteride and demonstrated hair growth in male pattern hair loss. On December 22, 1997, the FDA approved finasteride to treat male pattern hair loss.
Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride

Function

1) Used for treatment of hair loss;

2) For the treatment of benign prostatic hyperplasia, enlarged prostate shrink, improve urinary flow and improvement of benign prostatic hyperplasia caused symptoms.

Benign prostatic hyperplasia

Physicians use finasteride for the treatment of BPH, informally known as an enlarged prostate. The FDA-approved dose is 5 mg once a day. Six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment.  If the drug is discontinued, any therapeutic benefits reverse within about -8 months. Finasteride may improve the symptoms associated with BPH such as  difficulty urinating, getting up during the night to urinate, hesitation at the start of urination, and decreased urinary flow.

Male pattern baldness

Finasteride is used to treat male pattern hair loss (androgenetic alopecia) in men only. Treatment provides about 30% improvement in hair loss after six months of treatment,  and effectiveness only persists as long as the drug is taken.

Off-label uses

Finasteride is sometimes used in hormone replacement therapy for male-to-female transsexuals in combination with a form of estrogen due to its antiandrogen properties. However, little clinical research of finasteride use for this purpose has been conducted and  evidence of efficacy is limited.

Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride
Item Specification Test Results
Characteristics White or off-white crystalline powder Complies
Soluility Freely soluble in metlene loride and in alcohol;practically insoluble in water Complies
Identification IR-Spectrum
HPLC
Complies
Specific Rotation -50°~-60° -58°
Water ≤0.3% 0.1%
Residue on Ignition ≤0.1% 0.01%
Heavy Metals ≤10 <10
Relative Material Major≤0.5
Total≤1.0
0.3
0.5
Residual Solvent Complies Complies
Assay 98.5%~101.0% 99.2%
Conclusion The result conforms the standard
Hair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride FinasterideHair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride FinasterideHair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride FinasterideHair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride FinasterideHair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride FinasterideHair Loss Treatment CAS 98319-26-7 Minoxidil Dutasteride Finasteride

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier